Multiple linear regression analysis showed that a combination of regulatory mechanisms, including PRKACA copy number alterations, transcription factor expression levels, promoter methylation status, and miRNA expression levels, independently predicted PRKACA expression in the CRC cohort (Table 4; Figure 5). The gene discussed is PRKACA; the disease is colorectal carcinoma.